Sweta Patel, the third and final party targeted in the Cellular Nucleonic Advantage steroid investigation, has pleaded guilty to one count of criminal diversion of a prescription medication. A sentence of five years probation is expected as a condition of her plea agreement. She joins founder Benjamin Eugene Bolton and Monday Miller who have previously pleaded guilty and agreed to cooperate as witnesses for investigators in the prosecution of compounding pharmacies in order to avoid prison [...]
thinksteroids.com
Cellular Nucleonic Advantage Steroid Investigation Ends With Third Guilty Plea - MESO-Rx
Sweta Patel, the third and final party targeted in the Cellular Nucleonic Advantage steroid investigation, has pleaded guilty to one count of criminal
thinksteroids.com
